Evidence map›Paper›PMID 33302498›Full record

ReviewInternational journal of environmental research and public health2020

Oral Cancer and Precancer: A Narrative Review on the Relevance of Early Diagnosis.

Silvio Abati, Chiara Bramati, Stefano Bondi, Alessandra Lissoni, Matteo Trimarchi

3 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 170 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
170citing papers in PubMed, 8 pooled it
25.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05562375 narecruitingnot on this mapstarted 2022, after this paper: background citation

Predictive Value of GOCCLES® (Glasses for Oral Cancer Curing Light Exposed Screening), Device for Early Diagnosis of Oral Potentially Malignant Disorders

TypeinterventionalSponsorUniversidad Rey Juan CarlosRan2022 to 2026Enrolled73ConditionsOral Potentially Malignant Disorders, Oral CancerArmsGOCCLES, Toluidine blue stain, Biopsy
NCT06231537 nacompletednot on this mapstarted 2023, after this paper: background citation

Visual Oral Examination in Primary Health Care for Early Detection of Oral Cancer: Targeting High-Risk Individuals in the Municipality of Rio de Janeiro

TypeinterventionalSponsorUniversidade Federal do Rio de JaneiroRan2023 to 2024Enrolled1,152ConditionsMouth NeoplasmsArmsVisual oral examination
NCT06732609 recruitingnot on this mapstarted 2024, after this paper: background citation

Clinical Evaluation and Characterization of Normal Perioral Tissue With a New Advanced Videodermoscopy Method. A Pilot Study on Dental Students.

TypeobservationalSponsorFondazione Policlinico Universitario Agostino Gemelli IRCCSRan2024 to 2025Enrolled80ConditionsOral Mucosal Disorder
3 · Its place in the literature

Who cites it

170 citing papers in PubMed, 8 syntheses or guidelines pooled it, 386 citations in OpenAlex.

  1. C-reactive protein and its ratio with albumin as a marker of poor prognosis in oral cancer: a systematic review and meta-analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Review
  14. Review
  15. Observational
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

110 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Silvio AbatiDentistry and Stomatology-IRCCS San Raffaele Hospital, University Vita-Salute, 20132 Milano, Italy.ORCID 0000-0002-3226-8242
Chiara BramatiSchool of Medicine, University Vita-Salute, 20132 Milano, Italy.
Stefano BondiOtorhinolaryngology-Head & Neck Surgery Department, San Raffaele Hospital, University Vita-Salute, 20132 Milano, Italy.
Alessandra LissoniDentistry and Stomatology-IRCCS San Raffaele Hospital, University Vita-Salute, 20132 Milano, Italy.ORCID 0000-0003-3053-8832
Matteo TrimarchiSchool of Medicine, University Vita-Salute, 20132 Milano, Italy.ORCID 0000-0001-6472-3484
Vita-Salute San Raffaele University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oral cancer (OC) is an uncommon malignancy in Western countries, being one of the most common cancers in some high-risk areas of the world. It is a largely preventable cancer, since most of the different risk factors identified, such as tobacco use, alcohol consumption, and betel nut chewing, are behaviors that increase the likelihood of the disease. Given its high mortality, early diagnosis is of utmost importance. Prevention and the anticipation of diagnosis begin with identification of potentially malignant lesions of the oral mucosa and with local conditions promoting chronic inflammation. Therefore, every lesion must be recognized promptly and treated adequately. The clinical recognition and evaluation of oral mucosal lesions can detect up to 99% of oral cancers/premalignancies. As stated by the World Health Organization, any suspicious lesion that does not subside within two weeks from detection and removal of local causes of irritation must be biopsied. Surgical biopsy remains the gold standard for diagnosis of oral cancer. Adjunctive tools have been developed and studied to help clinicians in the diagnostic pathway, such as toluidine blue vital staining and autofluorescence imaging. In the near future other methods, i.e., identification of salivary markers of progression may help in reducing mortality due to oral cancer.

Indexed as

Early Detection of CancerMouth NeoplasmsPrecancerous ConditionsBiopsyHumansMouth Mucosaoral canceroral healthoral healthcareoral pathologypre-malignanciesprimary preventionrisk factors

Identifiers

PMID33302498
PMCPMC7764090
OpenAlexW3111800792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.